Osiris Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2017
Net Income before Extraordinaries
11,065.00
603.00
8,852.00
8,785.00
Depreciation, Depletion & Amortization
708.00
587.00
940.00
688.00
Other Funds
75.00
74.00
248.00
-
Funds from Operations
7,057.00
10,046.00
12,647.00
223.00
Changes in Working Capital
6,214.00
3,555.00
15,802.00
5,446.00
Net Operating Cash Flow
13,271.00
13,601.00
3,155.00
5,223.00
Capital Expenditures
128.00
528.00
1,123.00
2,008.00
Sale of Fixed Assets & Businesses
-
19,751.00
-
-
Purchase/Sale of Investments
13,452.00
7,283.00
2,182.00
7,351.00
Net Investing Cash Flow
13,324.00
11,940.00
1,059.00
5,343.00
Issuance/Reduction of Debt, Net
22.00
44.00
45.00
-
Net Financing Cash Flow
140.00
2,223.00
1,888.00
128.00
Net Change in Cash
193.00
562.00
208.00
248.00
Free Cash Flow
13,399.00
14,129.00
4,278.00
7,231.00
Deferred Taxes & Investment Tax Credit
2,188.00
-
-
-
Change in Capital Stock
87.00
2,193.00
1,685.00
128.00
About Osiris Therapeutics
View Profile
